October 22, 2015
This is the second year in a row that the industry newsletter has honored Amneal.
October 22, 2015

Camber has unveiled its generic of Merck’s Singulair (montelukast sodium) chewable tablets for chronic asthma treatment. 

October 22, 2015

Guanfacine extended-release tablets are indicated to treat attention deficit/hyperactivity disorder in children and adolescents ages 6 to 17.

October 22, 2015

The new facility features 500,000 square feet of warehouse space and 12,700 square feet of office space, which is approximately 25 times larger than its original building on Sidney Street.

October 21, 2015

“This crisis is taking lives — it’s destroying families and shattering communities all across the country,” President Obama said in remarks at a community forum meant to kick off his administration’s new push to curb opioid abuse. 

October 20, 2015

A new generics supplier has come to the United States with Alembic Pharmaceuticals’ launch of its Namenda generic.

October 16, 2015

Last month’s launch of the first generic biologic drug in the United States is the first step in a movement that some say could drive down the nation’s healthcare bill and bring new treatment options to thousands of patients across the country.

October 16, 2015

Greenstone announced this week that it had introduced its authorized generic of Zarontin (ethosuximide) capsules and oral solution.

October 16, 2015

Sandoz on Friday announced that it had launched its generic version of Novartis’ Lescol XL (fluvastatin) extended-release tablets. 

October 13, 2015

Aurobindo’s latest approval is for an antipsychotic meant to treat bipolar disorder and schizophrenia. 

October 12, 2015

Teva Pharmaceuticals on Monday announced the launch of its generic of GlaxoSmithKline’s Avodart.

October 9, 2015

The New York Times outlines the controversy surrounding the recent FDA approval of Oxycontin in children. “Just because OxyContin has been abused or prescribed inappropriately doesn’t mean we should deprive the children who need the drug,” Kathleen Neville, pediatric oncologist at Arkansas Children's Hospital told The New York Times, adding it is “our obligation to have the best level of evidence for its use in children.” (The New York Times)

 

 
 
October 8, 2015

More than 80% of Americans support medical school and physician residency programs to provide training for physicians in how to treat chronic pain and how to detect and treat addiction to prescription pain medication. 

October 7, 2015

Approximately 4 in 5 U.S. adults in their 40s (80%) and 50s (83%) reported concern around the security of their health data. 

October 7, 2015

Camber Pharmaceuticals has rolled out its generic version of Mirapex and Plavix.

October 7, 2015

More than 260,000 pharmacists have been trained to provide immunization services through APhA, association says. 

October 5, 2015

Overall, 22% of consumers who are enabling their health management through technology in 2015 vs. 13% two years ago.

October 5, 2015

The Generic Pharceutical Association’s CEO and President Chip Davis offered his recommendations for the Trans-Pacific Partnership. 

October 5, 2015

The New York Times outlines the impact price increases of Valeant Pharmaceutical's Cuprimine has on one family, juxtaposing Valeant's pharmaceutical business model against the threat of government action. “Cuprimine is just one of many Valeant drugs whose prices have spiked as part of the company’s concerted strategy, which has richly rewarded its investors and made it one of Wall Street’s most popular health stocks,” the article said. “But Valeant’s habit of buying up existing drugs and raising prices aggressively, rather than trying to develop new drugs, has also drawn the ire of lawmakers and helped stoke public outrage against the growing trend of higher and higher drug prices imposed by big drug companies.” (New York Times)

 

 

October 1, 2015

Sanofi announced Thursday that it had launched its generic of Arava (lefluniomide) tablets through its U.S. generics division Winthrop.

October 1, 2015

Tussionex has launched its generic of Tussionex, taking over marketing and distribution from Par Pharmaceuticals after Par's rights to the drug expire. 

September 28, 2015

Dr. Reddy's is the latest company to introduce a generic version of AstraZeneca’s Nexium capsules. 

September 28, 2015

As a result of the $8.05 billion acquisition, Endo has adjusted its guidance for FY2015.

September 28, 2015

Aurobindo’s latest generic is of Pfizer’s Lopid, which treats high cholesterol alongside diet and exercise.